Cost of Anti-retroviral Medicines in Indonesia
|
ARVs |
Price of patented ARV before 2000 (per 60 tablets) (US$) |
Price of patented ARV after 2000 (per 60 tablets) (US$) |
Price of generic ARV after government-use authorization (per 60 tablets) (US$) |
|
Lamivudine + zidovudine + nevirapine |
800-1,000 |
600 |
18-65* |
|
Lamivudine (3TC) |
NA |
290-330** |
28 |
|
Nevirapine (Viramune) |
NA |
96 |
28 |
|
Lamivudine + zidovudine (Combivir) |
NA |
400 |
48.60 |
*The range of subsidized and full-cost prices that patients have to pay.
**The price range in different pharmacies. Indonesia does not have price control on medicines and therefore pharmacies and hospitals charge different prices
Note: The brands of the patented ARVs are in brackets.
Source: Lutifyah and Hira (2006). Data obtained through interview with PT Kimia Farma, the Indonesian generic manufacturer. Cited in M Khor, “Patents, Compulsory Licenses and Access to Medicines: Some Recent Experiences,” Third World Network, 2009.
Kaletra or Aluvia (lopinavr+ritonavir marketed by Abbott Laboratories) costs $83.3 per patient per month, over $1,000 per patient per year for public programs. The private sector price is several times more. (Abbott Laboratories, November 2011)
Back to HIV/AIDS Treatment in Indonesia Next to Funding for HIV/AIDS Initiatives